Code
Hierarchy
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Inclusion Terms
E25.8
-
Idiopathic adrenogenital disorder
Use Additional
E25.8
-
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Includes
-
adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis
-
Female adrenal pseudohermaphroditism
-
Female heterosexual precocious pseudopuberty
-
Male isosexual precocious pseudopuberty
-
Male macrogenitosomia praecox
-
Male sexual precocity with adrenal hyperplasia
-
Male virilization (female)
Excludes 1
- Q56 Indeterminate sex and pseudohermaphroditism
-
chromosomal abnormalities (Q90-Q99)
- Q90-Q99 Chromosomal abnormalities, not elsewhere classified (Q90-Q99)
-
galactorrhea (N64.3)
- N64.3 Galactorrhea not associated with childbirth
-
gynecomastia (N62)
- N62 Hypertrophy of breast
- P70-P74 Transitory endocrine and metabolic disorders specific to newborn (P70-P74)